4.7 Review

Use of Volumetry for Lung Nodule Management: Theory and Practice

期刊

RADIOLOGY
卷 284, 期 3, 页码 630-644

出版社

RADIOLOGICAL SOC NORTH AMERICA
DOI: 10.1148/radiol.2017151022

关键词

-

资金

  1. Irwin Mitchell
  2. Agfa
  3. Roche
  4. Boehringher Ingelheim

向作者/读者索取更多资源

A consistent feature of many lung nodule management guidelines is the recommendation to evaluate nodule size by using diameter measurements and electronic calipers. Traditionally, the use of nodule volumetry applications has primarily been reserved for certain lung cancer screening trials rather than clinical practice. However, even before the first nodule management guidelines were published more than a decade ago, research has been ongoing into the use of nodule volumetry as a means of measuring nodule size, and this research has accelerated in recent years. This article aims to provide radiologists with an up-todate review of the most recent literature on volumetry and volume doubling times in lung nodule management, outlining their benefits and drawbacks. A brief technical review of typical volumetry applications is also provided. (C) RSNA, 2017

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Respiratory System

Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial

Philip A. J. Crosbie, Rhian Gabe, Irene Simmonds, Neil Hancock, Panos Alexandris, Martyn Kennedy, Suzanne Rogerson, David Baldwin, Richard Booton, Claire Bradley, Mike Darby, Claire Eckert, Kevin N. Franks, Jason Lindop, Sam M. Janes, Henrik Moller, Rachael L. Murray, Richard D. Neal, Samantha L. Quaife, Sara Upperton, Bethany Shinkins, Puvan Tharmanathan, Matthew E. J. Callister

Summary: Telephone risk assessment followed by a community-based LHC is an effective strategy for lung cancer screening implementation. However, lower participation associated with current smoking status and socioeconomic deprivation underlines the importance of research to ensure equitable access to screening.

EUROPEAN RESPIRATORY JOURNAL (2022)

Review Radiology, Nuclear Medicine & Medical Imaging

Important parameters for cost- effective implementation of lung cancer screening

Helen Morgan, David r Baldwin

Summary: Low-dose computed tomography (LDCT) for lung cancer screening has been widely accepted for reducing late-stage diagnoses and mortality. However, the economic costs associated with screening need to be considered. Various health economic models have shown significant variation in cost per Quality-Adjusted Life Year (QALY), influenced by healthcare costs and modifiable program components. Recent studies using UK costs suggest most scenarios are within the willingness to pay threshold. Identifying the most clinically and cost-effective program is crucial, considering factors such as population selection, participation rate, screening intervals, nodule management, and clinical workup.

BRITISH JOURNAL OF RADIOLOGY (2023)

Article Critical Care Medicine

The Impact of COVID-19 on Lung Cancer Incidence in England

Savannah Gysling, Helen Morgan, Onosi Sylvia Ifesemen, Douglas West, John Conibear, Neal Navani, Emma Louise O'Dowd, David R. Baldwin, David Humes, Richard Hubbard

Summary: This retrospective observational study examined the incidence rates of lung cancer in England in 2019 and 2020. It found that there was a significant 26% reduction in lung cancer incidence during the first national lockdown in 2020, which gradually recovered to baseline without overcompensation later in the year.
Article Respiratory System

European Respiratory Society guideline on various aspects of quality in lung cancer care

Torsten Gerriet Blum, Rebecca L. Morgan, Valerie Durieux, Joanna Chorostowska-Wynimko, David R. Baldwin, Jeanette Boyd, Corinne Faivre-Finn, Francoise Galateau-Salle, Fernando Gamarra, Bogdan Grigoriu, Georgia Hardavella, Michael Hauptmann, Erik Jakobsen, Dragana Jovanovic, Paul Knaut, Gilbert Massard, John McPhelim, Anne-Pascale Meert, Robert Milroy, Riccardo Muhr, Luciano Mutti, Marianne Paesmans, Pippa Powell, Paul Martin Putora, Janette Rawlinson, Anna L. Rich, David Rigau, Dirk de Ruysscher, Jean-Paul Sculier, Arnaud Schepereel, Dragan Subotic, Paul Van Schil, Thomy Tonia, Clare Williams, Thierry Berghmans

Summary: This guideline provides good quality recommendations in lung cancer care, based on systematic reviews and evidence syntheses. The recommendations cover various quality improvement measures, such as avoiding delays in diagnosis and treatment, integrating multidisciplinary teams, adhering to guidelines, and using specific tools for decision-making. The recommendations should be periodically updated as new evidence becomes available.

EUROPEAN RESPIRATORY JOURNAL (2023)

Review Medicine, General & Internal

Lung cancer screening

Scott J. Adams, Emily Stone, David R. Baldwin, Rozemarijn Vliegenthart, Pyng Lee, Florian J. Fintelmann

Summary: Randomised controlled trials have shown that low-dose CT lung cancer screening reduces mortality compared with chest radiography or no screening. However, uncertainties remain about optimizing clinical and cost effectiveness. This Review provides an international perspective on lung cancer screening, covering clinical trials, identification of individuals who benefit, management of screen-detected findings, smoking cessation interventions, cost-effectiveness, artificial intelligence and biomarkers, and challenges and opportunities in implementation.

LANCET (2023)

Article Respiratory System

Impact of radiographer immediate reporting of X-rays of the chest from general practice on the lung cancer pathway (radioX): a randomised controlled trial

Nick Woznitza, Bhagabati Ghimire, Anand Devaraj, Sam M. Janes, Keith Piper, Susan Rowe, Angshu Bhowmik, Natasha Hayes, Daniel Togher, Nikita Arumalla, Erik Skyllberg, Iain T. H. Au-Yong, Susan Geary, Bindu George, Sarah Sheard, Stephen Ellis, Zoheb Shah, Sue Maughn, Stephen W. Duffy, David Baldwin

Summary: The study found that immediate reporting of chest X-rays from primary care can reduce the time to diagnose lung cancer by half, likely due to faster progression to CT. Radiographer reports are comparable in accuracy to local radiologist reports.

THORAX (2022)

Article Respiratory System

Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context

Harriet D. Quinn-Scoggins, Rachael L. Murray, Samantha L. Quaife, Pamela Smith, Kate E. Brain, Matthew E. J. Callister, David R. Baldwin, John Britton, Philip A. J. Crosbie, Rebecca Thorley, Grace M. McCutchan

Summary: A personalized intervention booklet utilizing LDCT scan images has been developed to help smokers quit. The study found that the visual presentation of images had the greatest impact on promoting cessation, and that trained practitioners were important in guiding individuals through the intervention. However, the emphasis on absolute and relative risk may have a demotivating effect.

BMC PULMONARY MEDICINE (2022)

Article Respiratory System

Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard

David R. Baldwin, Emma L. O. ' Dowd, Ilona Tietzova, Anna Kerpel-Fronius, Marjolein A. Heuvelmans, Annemiek Snoeckx, Haseem Ashraf, Hans -Ulrich Kauczor, Blin Nagavci, Matthijs Oudkerk, Paul Martin Putora, Witold Ryzman, Giulia Veronesi, Andrea Borondy-Kitts, Antoni Rosell Gratacos, Jan van Meerbeeck, Torsten G. Blum

Summary: The European Respiratory Society (ERS) has formed a collaborative group to provide a technical standard for the implementation of lung cancer screening, ensuring high quality and effectiveness.

EUROPEAN RESPIRATORY JOURNAL (2023)

Article Critical Care Medicine

Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19 & BULL;67 million people and evaluation of model performance against seven other risk prediction models

Weiqi Liao, Carol A. C. Coupland, Judith Burchardt, David R. Baldwin, Fergus Collaborators DART Initiat, Fergus Gleeson, Julia Hippisley-cox

Summary: This study aimed to develop and validate a risk prediction model (CanPredict (lung) model) for lung cancer screening in the UK and compare its performance with seven other risk prediction models. The model showed excellent discrimination, calibration, and net benefit, outperforming the other models. If implemented in primary care, the model has the potential to identify individuals at high risk of lung cancer for targeted screening.

LANCET RESPIRATORY MEDICINE (2023)

Article Medicine, General & Internal

Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals

Rebecca Landy, Vivian L. Wang, David R. Baldwin, Paul F. Pinsky, Li C. Cheung, Philip E. Castle, Martin Skarzynski, Hilary A. Robbins, Hormuzd A. Katki

Summary: By reusing LDCT images with deep learning algorithms or statistical models, the harms of low-dose computed tomographic (LDCT) screening can be reduced and the cost-effectiveness can be improved. This study aimed to identify low-risk individuals and estimate how many lung cancers would have been delayed by 1 year in diagnosis if they had been assigned a biennial screening.

JAMA NETWORK OPEN (2023)

Editorial Material Critical Care Medicine

Measuring Harms of Lung Cancer Screening An Opportunity to Improve Outcomes

David R. Baldwin

Editorial Material Respiratory System

Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset

Helen Morgan, Savannah Gysling, Neal Navani, David Baldwin, Richard Hubbard, Emma O'Dowd

Summary: Early changes in lung cancer care have significant impact on survival, with decreased diagnosis during lockdown leading to lower survival rates. Decreased survival was observed from the first national lockdown onwards and within 90 days of diagnosis. People diagnosed at the end of 2020 had the highest hazard ratios for death within 90 days and between 91 and 270 days.

THORAX (2023)

Article Respiratory System

Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD

Claire Bradley, Panos Alexandris, David R. Baldwin, Richard Booton, Mike Darby, Claire J. Eckert, Rhian Gabe, Neil Hancock, Sam Janes, Martyn Kennedy, Jason Lindop, Richard D. Neal, Suzanne Rogerson, Bethany Shinkins, Irene Simmonds, Sara Upperton, Jorgen Vestbo, Philip A. J. Crosbie, Matthew E. J. Callister

Summary: Spirometry offered alongside LDCT screening can potentially identify cases of undiagnosed and misdiagnosed COPD. Future research should assess the downstream impact of these findings and determine the impact of co-delivering spirometry on other parameters of LDCT screening.

ERJ OPEN RESEARCH (2023)

Review Oncology

Defining the road map to a UK national lung cancer screening programme

Emma L. O'Dowd, Richard W. Lee, Ahsan R. Akram, Emily C. Bartlett, Stephen H. Bradley, Kate Brain, Matthew E. J. Callister, Yan Chen, Anand Devaraj, Sinan R. Eccles, John K. Field, Jesme Fox, Seamus Grundy, Sam M. Janes, Martin Ledson, Melanie MacKean, Anne Mackie, Kieran G. McManus, Rachael L. Murray, Arjun Nair, Samantha L. Quaife, Robert Rintoul, Anne Stevenson, Yvonne Summers, Louise S. Wilkinson, Richard Booton, David R. Baldwint, Philip Crosbie

Summary: Lung cancer screening with low-dose CT has been recommended by the UK National Screening Committee based on trials showing a reduction in lung cancer mortality. The UK has made significant progress in addressing logistical issues and implementing targeted lung cancer screening through clinical trials and the NHS England Targeted Lung Health Check Programme. This Policy Review provides a summary of the consensus and key requirements for effective implementation of a screening programme, and can serve as a valuable resource for countries planning their own lung cancer screenings.

LANCET ONCOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

The role of computer-assisted radiographer reporting in lung cancer screening programmes

Helen Hall, Mamta Ruparel, Samantha L. Quaife, Jennifer L. Dickson, Carolyn Horst, Sophie Tisi, James Batty, Nicholas Woznitza, Asia Ahmed, Stephen Burke, Penny Shaw, May Jan Soo, Magali Taylor, Neal Navani, Angshu Bhowmik, David R. Baldwin, Stephen W. Duffy, Anand Devaraj, Arjun Nair, Sam M. Janes

Summary: This report examines the accuracy of trained reporting radiographers using CADe support to report LDCT scans. The findings show that the sensitivity of the reporting radiographers was 68-73.7% with a specificity of 92.1-92.7%. We cannot recommend CADe-supported radiographers as the sole reader of LDCT scans, but propose potential avenues for further research.

EUROPEAN RADIOLOGY (2022)

暂无数据